|
|
|
|
Jung B, Påhlman L, Johansson R and Nilsson E. Rectal cancer treatment and outcome in the elderly: an audit based on
the Swedish rectal cancer registry 1995–2004. BMC Cancer 2009; 9: 68.
Läs hela artikeln här!
Sorbye H, Pfeiffer P, Wetnzel-Larsen T, Cavalli-Björkman N, Glimelius B. Clinical trial enrollment, patient
characteristics, treatment choices and survival in prospectively registered metastatic colorectal cancer patients. Cancer
2009; 115:4679-87.
Kodeda K, Holmberg E, Steineck G, Nordgren S. Regional Differences in Local Recurrence Rates after Rectal Cancer
Surgery. Colorectal Dis 2009 Nov 14. [Epub ahead of print].
Gurmu A, Matthiessen P, Nilsson S, Påhlman L, Rutegård J, Gunnarsson U. Is para-stomal hernia a clinical, or a
radiological diagnosis? (Manuscript).
Olsson L, Granström F & Påhlman L. Restorative surgery in rectal cancer is associated with patients´ income.
(Manuscript).
Folkesson J, Ehrnrooth E, Engholm G, Kejs AM, Påhlman L, Wibe A, Tryggvadottir L, Brewster DH, Hakulinen T & Storm
H. Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer
2009; 125: 2406-2412.
Kressner M, Bohe M, Cedermark B, Dahlberg M, Damber L, Lindmark G, Öjerskog B, Sjödahl R, Johansson R, Påhlman L. The
impact of hospital volume on surgical outcome for rectal cancer – a survey of the Swedish Rectal Cancer Register. Dis Colon
Rectum 2009; 52: 1542-1549.
Kressner M, Nilsson P, Johansson R, Glimelius B, Påhlman L. The effect of short-term pre-operative irradiation
on cancer on different levels of the rectum - Local recurrence and survival in. The Swedish Rectal Cancer Register. (Manuscript).
Jörgren F, Johansson R, Damber L, Lindmark G. Risk Factors of Rectal Cancer Local Recurrence: Population-based Survey
and Validation of the Swedish Rectal Cancer Registry. Colorectal Dis 2009 Apr 27. [Epub ahead of print].
Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and
without preoperative radiation therapy. Br J Surg 2008; 95: 206-13.
Syk E, Torkzad MR, Blomqvist L, Nilsson PJ, Glimelius B. Local recurrence in rectal cancer: Anatomical localization and
impact on radiation target. Int J Radiat Oncol Biol Phys 2008; 72: 658-64.
van Leeuwen B, Påhlman L, Gunnarsson G, Sjövall A & Martling A. The effect of age and gender on outcome after
surgery for colon carcinoma. A population based study in the Uppsala and Stockholm region. Critical Rev Oncol/Hematol 2008;
67: 229-236.
Jestin P, Påhlman L, Gunnarsson U. Risk factors for anastomotic leakage after rectal cancer surgery: a
case-control study. Colorectal Dis 2008; 10: 715-721.
Glimelius B, Sorbye H, Balteskard L, Bystrom P, Pfeiffer P, Tveit K, Heikkila R, Keldsen N,
Albertsson M, Starkhammar H, Garmo H, Berglund Å. A randomized phase III multicenter trial comparing irinotecan in
combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2)
in pa-tients with metastatic colorectal cancer. Annals of Oncology 2008; doi: 10.1093/ annonc/mdm588.
Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, Öjerskog B, Damber L & Johansson R. The Swedish
Rectal Cancer Registry. Br J Surg 2007; 94: 1285-1292.
Folkesson J, Johansson R, Påhlman L, & Gunnarsson U. Local surgery for rectal cancer – A population based
study. Br J Surg 2007; 94: 1421-1426.
Lennarthson B, Andershed B. Patientens upplevelse av livskvalitet efter kolorektal-kirurgi.
En litteraturstudie. (D-uppsats). Omvårdnadsvetenskap. Hälsovetenskapliga institutionen. Örebro Universitet 2007.
Läs artikeln här.
Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, Iddenden R, Møller H, Sankila R,
Thomson CS, Storm HH. Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis
of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007; 121: 1115-1122.
Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, Iddenden R, Møller H, Sankila R,
Thomson CS, Storm HH. Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis
of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007 Apr 23; [Epub ahead
of print].
Jestin P, Påhlman L, Glimelius B & Gunnarsson U. Cancer staging and survival in colon cancer is depending on the
quality of the pathologists’ specimen examination. Eur J Cancer 2005; 41: 2071-2078.
Larsson SC, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon,
distal colon, and rectum: The Swedish mammography cohort. Int J Cancer 2005; 113: 829-834.
Jestin P, Nilsson J, Heurgren L, Påhlman L, Glimelius B, Gunnarsson U. Emergency surgery for colonic cancer in a defined
population. Br J Surg Januari 2005; 92(1): 94-100.
Folkesson J, Nilsson J, Påhlman L, Glimelius B, Gunnarsson U. The circular stapling device as a risk factor for anastomotic leakage.
Colorectal Dis 2004; 6(4): 275-279.
Jestin P, Heurgren M, Påhlman L, Glimelius B, Gunnarsson U.
Elective surgery for colorectal cancer in a defined Swedish population. Eur J Surg Oncol 2004; 30(1): 26-33.
Cho E, Smith-Warner SA, Ritz J, van der Brandt PA, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Holmberg L,
Kim DH, Malila N, Miller AB, Pietinen P, Rohan TE, Sellers TA, Speizer FE, Willett WC, Wolk A, Hunter DJ. Alcohol intake and colorectal cancer:
a pooled analysis of 8 cohort studies. Ann Intern Med 2004; 140: 603-13.
Blom J, Lidén A, Nilsson J, Påhlman L, Nyrén O, Holmberg L. Colorectal cancer screening with flexible sigmoidoscopy – participants´
experiences and technical feasibility. Eur J Surg Oncol 2004; 30: 362-9.
Gunnarsson U. Quality assurance in surgical oncology - Colorectal cancer as an example. Eur J Surg Oncol 2003; 29(1): 89-94.
Gunnarsson U, Seligsohn E, Jestin P, Påhlman L. Registration and validity of surgical complications in colorectal cancer surgery. Br J
Surg April 2003; 90(4): 454-459.
Berglund Å, Molin D, Nordlinder R, Edler D, Graf W, Glimelius B. Thymidylate synthase and p53 expression in primary tumor do not predict
chemotherapy outcome in metastatic colorectal carcinoma. Anticancer Res 2002; 22: 3653-3659.
Jakobsen A, Berglund Å, Glimelius B, Frödin J-E, Hansen F, Kjaer M, Lindegaard Madsen E, Sandberg E, Poulsen JP, Gustavsson B, Carlsson G.
Dose-effect relationship of bolus 5-FU in the treatment of advanced colorectal cancer. A randomized study. Acta Oncol 2002; 41: 525-531.
Dahlberg M, Påhlman L, Glimelius B. Cost-effectiveness of preoperative radiotherapy in rectal cancer. Results from the Swedish Rectal Cancer
Trial. Int J Radiat Oncol Biol Phys 2002; 54: 654-660.
Berglund Å, Molin D, Larsson A, Einarsson R, Glimelius B. Tumour markers as predictors of response to chemotherapy in advanced colorectal
carcinoma. Ann Oncol 2002; 13: 1430-1437.
Edler D, Glimelius B, Hallström M, Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H. Thymidylate synthase expression in
colorectal cancer – a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 2002; 20:1721-1728.
Köhne C-H, Cunningham D, Di Costanzo F, Glimelius B, Blijham G, Arande E, Scheithauer W, Rougier P, Palmer M, Wils J, Baron B, Pignatti F,
Schöffski P, Micheel S, Hecker H. Clinical determinants of survival in patients with 5-fluorouracil based treatment for metastatic colorectal
cancer. Results of a multivariate analysis of 3825 patients. Ann Oncol 2002; 13: 308 - 317.
Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort
study in women. Nutr Cancer. 2002; 43: 39-46.
Blom J, Lidén A, Jeppsson B, Holmberg L, Påhlman L. Compliance and findings in a Swedish population screened for colorectal cancer with
sigmoidoscopy. Eur J Surg Oncol. 2002; 28: 827-831.
Terry P, Giovannucci E, Bergkvist L, Holmberg L, Wolk A. Body weight and colorectal cancer risk in a cohort of Swedish women: relation
varies by age and cancer site. Br J Cancer 2001; 85: 346-349.
Terry P, Bergkvist L, Holmberg L, Wolk A. No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol
Biomarkers Prev 2001; 10: 913-914.
Terry P, Bergkvist L, Holmberg L, Wolk A. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of
Swedish women. Gut 2001; 49: 87-90.
Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L, Wolk A. Fruit, vegetables, dietary fiber, and risk of colorectal
cancer. J Natl Cancer Inst 2001; 93: 525-533.
Nordin K, Hoffman K and Glimelius B. Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients.
Br J Cancer 2001; 85: 1265-1272.
Nordin K, Wasteson E, Hoffman K, Glimelius B, Sjödén P-O. Discrepancies between attainment and importance of life values and anxiety and
depression in gastrointestinal cancer patients and their spouses. Psycho-Oncol 2001; 10: 479-489.
Jansson Frykholm G, Påhlman L, Glimelius B. Combined chemo- and radiotherapy vs radiotherapy alone in the treatment of primary,
nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427-434.
Bohe M, Cedermark B, Damber L, Lindmark G, Nordgren S, Påhlman L & Sjödahl R. Kvalitetsregister etablerat för
bättre rektalcancerbehandling. Läkartidningen 2000; 97: 3587-3591.
Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colo-rectal cancer: systematic review and meta-analysis.
BMJ 2000; 321: 531-5.
Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H. Immunohistochemically detected
thymidylate synthase in colorectal cancer: An independent prognostic factor of survival. Clin Cancer Res 2000; 6: 488-492. |
|
